Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes

Abstract

BackgroundHomocysteine and pro-inflammatory mediators such as cyclooxygenase-2 (COX-2) have been linked to vascular dysfunction and risks of cardiovascular diseases. Fulvic acid (FA), a class of compounds of humic substances, possesses various pharmacological properties. However, the effect of FA on inflammatory responses of the monocytes remains unclear. We investigated the regulatory effect of FA on homocysteine-induced COX-2 expression in human monocytes.MethodsPeripheral blood monocytes and U937 cells were used for all experiments. Real-time PCR and ELISA assay were used to analyze the COX-2 mRNA expression and PGE2 secretion, respectively. Specific inhibitors were used to investigate the mechanism of homocysteine-mediating COX-2 mRNA expression and PGE2 secretion. Luciferase assay, transcription factor ELISA, and chromatin immunoprecipitation were used to determine the role of nuclear factor-κB in FA-mediated inhibition of homocysteine effect on monocytes.ResultsThe results show that pretreating monocytes with FA inhibited the homocysteine-induced COX-2 expression in a dose-dependent manner. Stimulation of U937 monocytes with homocysteine induced rapid increases in the phosphorylation of ERK and JNK; the inhibitor for ERK and JNK attenuated the homocysteine-induced nuclear factor-κB activation and COX-2 expression. Transcription factor ELISA and chromatin immunoprecipitation assays showed that FA blocked the homocysteine-induced increases in the binding activity and in vivo promoter binding of nuclear factor-κB in monocytes.ConclusionsOur findings provide a molecular mechanism by which FA inhibits homocysteine-induced COX-2 expression in monocytes, and a basis for using FA in pharmaceutical therapy against inflammation.

Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury

“…IL-6 [ 38 ] and IL-1β [ 39 ] are also the markers of inflammatory response induced by myocardial I/R. COX-2 is an enzyme that synthesized eicosanoids and is highly expressed upon the stimulation of cytokines and LPS [ 40 ]. PGE 2 is an inflammatory mediator regulated by COX-2 [ 41 ].…”

Therapeutic Potential of Fulvic Acid in Chronic Inflammatory Diseases and Diabetes

“…First, Junek et al show that FvA at 200 μ g/mL can reduce tumour necrosis factor alpha (TNF- α ) expression after exposure to the endotoxin Lipopolysaccharide (LPS) in differentiated human monocytes (U937) [ 14 ]. FvA also is shown to reduce cyclooxygenase 2 (COX2) and prostaglandin E2 (PGE2) secretion after homocysteine stimulation in primary human monocytes [ 15 ]. FvA from solubilized sludge (SS-FA) is shown to reduce B-hexosaminidase and histamine release in immunoglobulin-E-sensitized mast cells and basophil cells [ 16 ].…”

In vivo investigation of antihyperalgesic and antinociceptive effects of peat formulations

“…It was previously reported that the peat water extract could act as a selective COX-2 inhibitor (8,13). These results suggest that the mechanism of the antihyperalgesic effect of the peat water extract is more complex and involves not only partial activation of peripheral α 2 -adrenoceptors but also COX-2 inhibition.…”